Highlights d Asters are ER-resident proteins that mediate nonvesicular sterol transport d The sterol-binding ASTER domain is structurally related to the START domain d Asters are dynamically recruited to PM-ER contacts in response to cholesterol d Aster-B is required for delivery of HDL cholesterol from SR-BI to the ER in adrenals A nonvesicular pathway for plasma membrane to ER sterol trafficking in mammals is mediated by sterol-binding ER-resident Aster proteins.
INTRODUCTION
High-density lipoprotein (HDL) cholesterol levels in the plasma are inversely associated with coronary heart disease (CHD) risk, but recent genetic studies have strongly implied that HDL cholesterol levels are not causally related to risk for CHD (Rader and Tall, 2012) . For example, the P376L mutation in scavenger receptor class B member 1 (SR-BI) is associated with greater cardiovascular disease risk despite high plasma levels of HDL cholesterol (Zanoni et al., 2016) . Mounting evidence suggests that the function of HDL, in particular its role in cholesterol movement in cells and tissues, may be key to its role in physiology and disease (Khera et al., 2011; Rader, 2014) . HDL is important in the reverse cholesterol transport pathway that brings surplus cholesterol from peripheral tissues to the liver for excretion (Braun et al., 2002) . A better understanding of the pathways by which HDL cholesterol moves through cells and tissues may aid in the development of novel diagnostic tools and therapies.
Integral membrane receptors involved in cholesterol uptake at the plasma membrane (PM) have been characterized extensively, but comparatively little is known about mechanisms that traffic cholesterol from the PM to other compartments within the cell (Goldstein and Brown, 1985; Horton et al., 2002; Ikonen, 2008) . Scavenger receptor class B member I (SR-BI) is the principal cell-surface receptor for HDL (Acton et al., 1996) . SR-BI is abundant in steroidogenic organs and the liver, where WT (white) and LXR null (LXRaÀ/À and LXRbÀ/À, red) mouse peritoneal macrophages. Cells were treated with LXR ligand GW3965 (1 mM), with or without RXR ligand LG100754 (100 nM) for 16 hr. Values are means ± SEM. (B) ChIP-seq bedgraph of LXRa and LXRb binding patterns in mouse macrophages at the promoter region of the Gramd1b locus (Sallam et al., 2016 (Sallam et al., , 2018 Zhang et al., 2017) . Input (ctrl) served as a control for LXR enrichment.
it facilitates the selective uptake of cholesterol from HDL (Glass et al., 1983; Neculai et al., 2013) . In the liver, HDL cholesterol uptake facilitates reverse cholesterol transport by delivering surplus peripheral cholesterol to hepatocytes for secretion into bile or for conversion into bile acids. In steroidogenic organs, HDL-derived cholesterol accumulates in the form of cholesterol ester, and these stores are used for the synthesis of steroid hormones (Connelly, 2009; Hoekstra, 2017) . The selective HDL cholesterol uptake pathway is distinct from the LDLR pathway, by which LDL particles are taken up and delivered to lysosomes for degradation (Goldstein and Brown, 2015) . HDL cholesterol uptake does not require clathrin-dependent receptor-mediated uptake or lysosomal targeting, but what happens to HDL-derived cholesterol after SR-BI-mediated uptake is unknown. The pathways downstream of SR-BI that move cholesterol within the cell have not been defined. Dozens of candidate cholesterol-transfer proteins have been shown to be capable of mediating sterol transfer in vitro (Ikonen, 2008 (Ikonen, , 2018 ; however, assigning physiologic functions to those proteins has proven challenging. Three intracellular cholesterol-transfer proteins have been shown to have clear physiologic functions in vivo. The Niemann Pick type C proteins 1 and 2 (NPC1, NPC2) are critical for the export of LDL-derived cholesterol from the lysosome (Infante et al., 2008; Pfisterer et al., 2016) . Mutations in either NPC1 or NPC2 lead to accumulation of lysosomal lipids in vivo, explaining the phenotypes associated with Niemann Pick type C syndrome. Steroid acute regulatory protein (StARD1) is required for the trafficking of cholesterol to the mitochondrial inner membrane (Lin et al., 1995) . Mutations in StARD1 are the major cause of lipoid congenital adrenal hyperplasia.
The endoplasmic reticulum (ER) is known to form membrane contacts with other organelles, and these have been proposed to facilitate the transfer of small molecules between membranes (Chung et al., 2015; Lees et al., 2017; Zhang et al., 2005) . However, no mammalian transporter has yet been shown to be required for the trafficking of cholesterol from the PM to the ER (Ikonen, 2008 (Ikonen, , 2018 . Here, we characterize three mammalian proteins (Aster-A, -B, and -C) that bind and transfer cholesterol between membranes. Aster proteins are anchored to the ER by a single transmembrane helix and form ER-PM membrane contacts in response to PM cholesterol loading. We hypothesized that the Asters could be missing links in the trafficking of HDL-derived cholesterol to the ER. We found that Aster-B was selectively enriched in steroidogenic organs and that its expres-sion was required for the storage of HDL-derived cholesterol ester and steroidogenesis in the adrenal cortex. Our findings elucidate a nonvesicular pathway for PM-ER sterol trafficking in mammalian cells and suggest new mechanisms by which HDL-derived cholesterol is mobilized in a variety of physiological contexts.
RESULTS

A Family of Mammalian Lipid-Binding Proteins
We discovered that the Gramd1b gene was regulated by the sterol-responsive liver X receptors (LXRs) in mice, suggesting that it could play a role in sterol homeostasis (Janowski et al., 1996) . Gramd1b was induced by a synthetic LXR agonist in wild-type (WT), but not LXR null, mouse macrophages ( Figure 1A) . Moreover, chromatin immunoprecipitation sequencing (ChIP-seq) analyses revealed binding of LXRa and LXRb to the regulatory regions of Gramd1b, identifying it as a direct transcriptional target ( Figure 1B) . Gramd1b belongs to a family of highly conserved genes, designated Gramd1a, -b, and -c in databases. One-toone orthologs of Gramd1b are present in all vertebrate classes ( Figure S1A ). The predicted amino acid sequence of the human protein is 78% identical to that from Oreochromis niloticus (nile tilapia). These genes have not previously been characterized; their structures are incorrectly annotated in databases; and the function of their protein products is unknown. We determined the correct exon-intron structures of Gramd1a, , which are predicted to encode proteins of 723, 699, and 662 amino acids, respectively. We will refer to the protein products as Aster-A, -B, and -C. The genes are expressed in a tissue-specific manner in mice, with Gramd1a being most abundant in the brain; Gramd1b prominently expressed in steroidogenic tissues and macrophages; and Gramd1c expressed in liver and testes ( Figure S1C ). The Aster proteins contain an N-terminal GRAM domain, which is structurally similar to a pleckstrin homology domain (Begley et al., 2003) , and a single transmembrane domain near the C terminus ( Figure 1C ). The large central domain of the Aster proteins shows low sequence similarity to structurally characterized proteins. However, modeling programs such as Phyre and I-TASSER predicted that this central domain would resemble the sterol-binding domains from the mammalian StarD proteins and the Starkin domains from the yeast Lam proteins, despite minimal identity at the amino acid level. We named this mammalian START-like domain the ASTER (Greek for ''star'') domain. (C) Schematic representation of Aster-A, Aster-B, and Aster-C proteins. The N-terminal GRAM (green) , central ASTER (blue), and transmembrane (TM, red) domains are indicated. (D) Purified Aster domains (Aster-A 261-576 , ) bind to 22-NBD-cholesterol, but not 6-NBD-cholesterol, with nanomolar affinity. Values are means ± SEM. (E) Aster-B (1-10 mM) was titrated with 10-3,000 nM 22-NBD-cholesterol in PBS and fluorescent ligand binding determined. (F) Binding of [ 3 H]cholesterol to purified was assessed using a GST-agarose-based assay. Competition assays were performed using increasing concentrations of unlabeled cholesterol as indicated. Results values are means ± SD. (G) was titrated with 22-NBD-cholesterol in the presence of vehicle, estradiol, or various hydroxycholesterol (HC) sterol competitors as indicated (10 mM). Results values are means ± SD. (H) Sucrose-loaded heavy PC/Dansyl-PE liposomes and light PC/Dansyl-PE-Cholesterol liposomes were incubated with buffer or with 5 mM albumin, pre-heated (left, 95 C 3 10 min), or native Aster-A 261-576 , for 20 min at 25 C. Cholesterol transfer to the heavy liposomes was assessed and normalized to dansyl-PE recovery. Values are means ± SEM. All results are representative of at least two independent experiments. See also Figures S1E-S1G.
The ASTER Domain Binds Sterols and Promotes Their Transfer between Membranes
Molecular modeling of the ASTER domain indicated the presence of a hydrophobic pocket capable of accommodating a lipophilic molecule. To test their ability to bind lipids, we expressed and purified the ASTER domains from Aster-A, -B, and -C ( Figure S1D ). Using a fluorescent NBD-cholesterol binding assay, we found that all three Aster domains avidly bound sterols (Petrescu et al., 2001) . As shown in Figure 1D , increasing the concentration of NBD-cholesterol, while maintaining the concentration of the ASTER-domain constant, increased the fluorescence emission The crystal structure of the ASTER domain of the mouse Aster-A. The ribbon representation is colored from blue-red amino-carboxy terminus. The 25-hydroxycholesterol ligand is shown as atomic spheres: gray, carbon; red, oxygen. The right-hand panel is rotated 90 about the indicated axis. The ligandbinding pocket is situated between a concave betasheet and a long carboxy-terminal helix. (B) Details of the 25-hydroxycholesterol ligandbinding pocket. The left-hand panel shows key sidechains within the ligand pocket that mediate interaction with the ligand. Phe405, Tyr524, and Phe525 (cyan) seem to determine the orientation of the ligand and are markedly different in character from the equivalent residues in the yeast Lam proteins (see also Figure S3 ). (C) Cut-away view of the surface of mouse Aster A showing the ligand-binding pocket. The ligand is completely enclosed with the exception of an opening toward the left of the pocket. The pocket is significantly larger than the ligand beyond the C3-OH group. This additional space is occupied by a glycerol molecule. (D and E) Potential mechanism for loading cholesterol into the ASTER domain. Structural rearrangements would be essential for cholesterol to gain access to the binding pocket. This is likely to involve the loop comprising amino acids 430-439 that wraps around the ligand. The surface of this region of the ASTER domain is relatively nonpolar in character (see labeled amino acids), but with a number of prominent basic residues (D) . It seems likely that this region of the protein will come into contact with the negatively charged/nonpolar lipid bilayer into order to facilitate both loading and unloading of the cholesterol ligand (E) . See also Figure S2 . of NBD-cholesterol. Fitting the data to a single exponential yielded an average dissociation constant of <100 nM. By contrast, 6-NBD-cholesterol, binding of which would be predicted to place the NBD inside of the binding pocket, did not bind to the ASTER domains ( Figure 1D ). Using the Aster-B ASTER domain, we further confirmed increased NBD fluorescence in response to increasing protein concentration ( Figure 1E ). We also confirmed direct binding of [ 3 H]cholesterol to the Aster-B ASTER domain ( Figure 1F ).
Competition studies further showed that binding of NBDcholesterol to the ASTER domain was inhibited by 22-R, 25-, and 20a-hydroxycholesterol in addition to cholesterol itself (Figures 1G and S1E) . However, estradiol, 4b-, 22S-, and 7b-hydroxycholesterols were comparatively poor competitors. The inability of these oxysterols to compete for NBD-cholesterol binding suggests that the different binding affinities are not due to differences in the solubility of the different sterols. Finally, the affinity of the Asters for sterols was comparable to that of the sterol-binding domain from the canonical START domain protein StARD1 ( Figure S1F ).
To test the ability of the ASTER domain to transfer cholesterol between membranes, we optimized an in vitro assay with heavy and light liposomes (Chung et al., 2015) . The ASTER domain from Aster-A, -B, and -C, but not BSA, efficiently facilitated cholesterol transfer to the heavy liposomes ( Figure 1H ). Preheating the ASTER domain to 95 C for 10 min substantially reduced its activity. Interestingly, the ASTER domains were more efficient transporters of cholesterol in this assay than the START domain of the canonical StARD1 protein ( Figure S1G ).
Crystal Structure of the Aster Sterol-Binding Domain
To determine the structure and to characterize the mode of sterol binding, we crystalized the ASTER domain from Aster A (amino acids [aa]: 334-562) with 25-hydroxycholesterol. Despite the predicted similarity to the StARD and Lam proteins, solving the structure by molecular replacement proved to be challenging. A solution was found using a truncated model based on the structure of the first start domain from the yeast protein Lam4 (5YQJ) with 23% sequence identity (Tong et al., 2018) . The structure of the ASTER domain consists of a highly curved 7-stranded beta-sheet forming a groove to accommodate the hydroxycholesterol ligand. The cavity is closed by a long carboxy-terminal helix and two shorter helices following the amino-terminal beta-strand ( Figure 2A ). The electron density for the 25-hydroxycholesterol unambiguously defined the position and orientation of the sterol, which was identical in all four molecules within the asymmetric unit ( Figures 2B and S2A ). Interestingly, there was additional volume within the cholesterol-binding cavity adjacent to the C3-OH group of the cholesterol. Within this volume we observed electron density for a glycerol molecule adjacent to the hydroxyl group on the cholesterol ( Figures 2C and S2A ). Glycerol was present during purification of ASTER domain and was also used as a cryo-protectant. Interestingly, the glycerol is ideally sized to fill the remaining volume of the pocket that is not occupied by the hydroxycholesterol.
Despite the relatively low sequence identity, the three-dimensional structure of Aster A broadly resembles the START domain fold and is similar to the START-like domains in the Lam2 and Lam4 proteins (Horenkamp et al., 2018; Jentsch et al., 2018; Tong et al., 2018 ) (C-alpha root-mean-square deviation [RMSD] c.2Å ; Figure S2B ). However, sequence differences within the cholesterol-binding pocket result in a different binding mode for the ligand, such that in Aster-A the sterol is rotated by approximately 120 about the long axis of ligand compared with the ligands in the START domains. This appears to be a concerted effect of multiple amino acid differences, but, in particular, F405, Y524, and F525 in mouse Aster-A seem to influence the ligand orientation ( Figure 2B ). Interestingly these residues are conserved in all three mammalian Aster proteins, but not the yeast Lam proteins ( Figures S3A and S3B) .
The sterol-binding pocket within the ASTER domain is largely enclosed with the exception of a relatively small opening adjacent to the loop between beta-strands 3 and 4. For the sterol to gain access to the pocket it is very likely that this loop will open ( Figures 2D and 2E ). In all four complexes within the asymmetric unit, this loop has relatively high B-factors or could not be modeled, consistent with conformational flexibility. Interestingly, there is an abundance of surface-exposed nonpolar residues located at the ''tip'' of the Aster domain around the presumed opening of the sterol-binding cavity (Figures 2C and 2D) . Alongside these nonpolar residues, are a number of conserved basic residues. These give the tip of the ASTER domain an overall positive charge but with the opportunity to make nonpolar interactions. This conserved surface chemistry of Aster proteins may assist exchange of sterol with negatively charged/nonpolar phospholipid membranes through interaction with and/or partial insertion of the domain into the membrane.
Asters Are Integral ER Proteins Recruited to the PM by Cholesterol
The structure of the Aster proteins suggested that they may promote the transfer of cholesterol between biological membranes. A critical question, therefore, was where these proteins are located within cells. To determine the location of Aster-A, -B, and -C, we expressed N-terminally tagged fusion proteins in A431 and HeLa cells. When cultured in standard lipid-poor conditions (1% lipoprotein-deficient serum, LPDS), Aster proteins displayed a reticular pattern that largely overlapped with the ER marker Sec61b ( Figures 3A-3C and S4A ). An Aster-B fusion protein lacking the GRAM domain was also localized to the ER, but one containing the isolated GRAM domain was mainly located within the cytoplasm ( Figure 3A ).
We hypothesized that the ER-localized Aster proteins might facilitate lipid transfer by making transient contacts with another cellular membrane. Remarkably, we found that cholesterol loading by methyl-b-cyclodextrin resulted in the redistribution of all 3 Aster proteins to the periphery of the cell in close proximity to the PM ( Figures 3B and S4A ). Next, we visualized the location of GFP-Aster-A, -B and -C in A431 cells using live cell Airyscan imaging. When cells were cultured in low-cholesterol media (LPDS), all three Aster proteins showed a punctate pattern of distribution in ER structures throughout the cell (Figures 3C, S4B, and S4C). However, when cholesterol-cyclodextrin was added to the media, the Aster proteins were almost exclusively found in ER tubules that abutted the PM (yellow arrows). These findings suggested that Aster proteins were localizing to regions of PM-ER apposition and forming cholesterol-dependent bridges. We assessed the relationship of Aster-PM contacts to membrane contact associated with the proteins ORP5, E-Syt2, and E-Syt3 (Chung et al., 2015; Ghai et al., 2017; Giordano et al., 2013) . We analyzed the cellular location of GFP-Aster-B, ORP5, E-Syt2, and E-Syt3 in the presence or absence added cholesterol. In cells cultured in low-cholesterol media, ORP5, E-Syt2, and E-Syt3 were found predominantly in ER tubules located adjacent to the PM (Figures 4A, 4B , and S4D). By contrast, Aster-B was located throughout the ER under these conditions and showed minimal colocalization with ORP5, E-Syt2, or E-Syt3. Addition of cholesterol to the cells had little if any effect on the location of ORP5, E-Syt2, or E-Syt3, but caused a dramatic relocalization of Aster-B to ER tubules that were in close proximity to the PM. Moreover, there was substantial, but not complete, overlap of Aster-B signal with signals for ORP5, E-Syt2, and E-Syt3 in cholesterol-loaded cells (quantified in Figure 4C ). Interestingly, although ER-PM contacts containing Aster-B were frequently located in the same ER tubules in which ORP5, E-Syt2, or E-Syt3 resided, domains containing only Aster-B also could be readily be identified in proximity to the PM.
We further analyzed cholesterol-dependent Aster PM recruitment using total internal reflection (TIRF) microscopy. We analyzed A431 cells expressing GFP-Aster-B and Cherry-ORP5 after loading of the cells with cyclodextrin cholesterol. While ORP5 was detected in the TIRF plane regardless of cellular sterol status, Aster-B was rapidly recruited to the TIRF plane in response to cholesterol ( Figure 4D ; Video S1). We conclude from these studies that, in contrast to ORP5, E-Syt2, and E-Syt3, which reside in ER-PM contact sites regardless of cellular sterol status, Aster-B is selectively recruited to regions of ER-PM contact in response to excess cholesterol in the PM.
The Gram Domain Mediates Cholesterol-Dependent Aster Localization
The Aster proteins contain an N-terminal GRAM domain, a structural motif that is found in glucosyltransferases, Rab-like GTPase activators, myotubularins, and other membrane-associated proteins (Doerks et al., 2000) . Interestingly, the GRAM domains of myotubularins have been shown to interact with phospholipids (Begley et al., 2003) . We found that purified Aster-B GRAM domain interacted strongly with both phosphatidylserine (PS) and phosphatidic acid (PA) ( Figure 5A ). Given that phosphatidylserine is highly enriched in the inner leaflet of the PM, we further determined if the Aster-B GRAM domain was associated with phosphatidylserine-containing liposomes. Co-sedimentation assays revealed that the GRAM domain pelleted selectively with phosphatidylserine-containing liposomes ( Figure 5B ). The inclusion of cholesterol in PS-containing liposomes did not enhance their association with the GRAM domain.
To determine if the Aster GRAM domain was required for the cholesterol-dependent localization of Asters to the PM, we transfected HeLa and A431 cells with mutant form of Aster-B in which the GRAM domain had been deleted (Figures 5C and S4E) . Loss of the GRAM domain abolished recruitment of Asters to the PM in response to cholesterol. We also expressed the Aster-B GRAM domain alone in CHO-K1 and A431 cells ( Figure 5D ; Video S2). Under basal culture conditions, the soluble GRAM domain was cytoplasmic, but it was recruited to the PM upon cholesterol loading. TIRF microscopy confirmed that C-terminal GFP-tagged Aster-B GRAM domain was largely cytoplasmic in cells cultured in LPDS but that it was recruited to the PM in a time-and concentration-dependent manner after cholesterol loading ( Figure 5E ; Videos S3 and S4). We conclude that the phosphatidylserine-binding GRAM domain is both necessary and sufficient for cholesterol-dependent Aster redistribution.
Aster-B Is Required for Adrenal Sterol Homeostasis
Movement of cholesterol from the PM to the ER is an important step in the utilization of HDL-derived cholesterol after selective uptake by SR-BI. We hypothesized that Asters may contribute to cholesterol transport from SR-BI at the PM to the ER. To test this idea, we focused on the rodent adrenal gland, which depends on SR-BI-mediated uptake of HDL cholesterol for steroidogenesis (Rigotti et al., 1997) . Among the Aster proteins, Aster-B exhibited the highest expression in the adrenal gland, suggesting that it was likely to be the most physiologically relevant Aster family member in this tissue ( Figure S5A ) (Consortium and ENCODE Project Consortium, 2012) . We confirmed that Aster-B protein was expressed at high levels in the adrenal, similar to SR-BI ( Figure 6A ).
To assess the physiological relevance of cholesterol transport by Aster-B, we generated knockout mice by CRISPR/Cas9 editing ( Figures 6B and S5B ). By visual inspection, the adrenal glands of Aster-B-deficient mice were red, suggesting an absence of cholesterol ester stores ( Figure 6C ). Indeed, oil red O staining revealed a loss of neutral lipid stores in the adrenal cortex in Aster-B-deficient mice ( Figure 6D ), and electron microscopy revealed a complete absence of cytosolic lipid droplets ( Figure 6E ). While levels of free cholesterol in the adrenal gland were not different between genotypes, loss of Aster-B Aster-B Promotes PM to ER Cholesterol Transport Next, we investigated the consequence of loss of Aster function for sterol movement in cultured cells. Since Aster-B is poorly expressed in most cultured cell lines, we knocked down Aster-A expression, which is abundant 3T3-L1 cells. We assessed cholesterol movement from the PM to the ER following exogenous delivery by measuring 1. the activity of the SREBP-2 pathway and 2. the formation of cholesterol esters. Treatment of 3T3-L1 cells with an Aster-A-specific ASO (which nearly abolished Gramd1a expression) ( Figure 7 ) led to induction of SREBP-2 processing, increased LDLR protein levels, and increased expression of SREBP-2 target genes, including Hmcgr, and Hmgcs ( Figures 7A and 7B) . Moreover, the ability of exogenously added cyclodextrin-cholesterol to suppress SREBP-2 processing was clearly delayed in Aster-A-silenced cells. The fact that some suppression of the SREBP-2 pathway at later time points was still observed even with Aster-A ASO was not unexpected, since vesicular sterol transport pathways were presumably still operative. Interestingly, mRNA and protein expression of LXR target gene Abca1 was reciprocally reduced in the absence of Aster-A ( Figure 7C ), consistent with reduced ER cholesterol availability for oxysterol production. We further found that the rate at which cholesterol delivered to the PM was incorporated into CE was markedly slower in cells in which Aster-A was silenced ( Figure 7D ). Two hours after cholesterol addition the amount of CE formed in Aster-A-silenced cells was less than 25% of controls cells.
Rodent adrenal glands rely on the selective uptake of HDL cholesterol by SR-BI to provide free cholesterol for the generation of cholesterol esters by the ER enzyme ACAT1. Interestingly, the adrenal phenotype of Aster-B knockout mice is virtually identical to that described for mice lacking SR-BI or ACAT1 (Meiner et al., 1996; Rigotti et al., 1997) . We therefore assessed whether HDL-mediated cholesterol delivery to cells affected Aster-B localization. Indeed, TIRF microscopy showed that incubation of A431 cells with HDL2 stimulated recruitment of Aster-B to the PM (Figures S6A-S6E ).
Next, we assessed whether Aster-B was important for HDL cholesterol delivery to adrenal cortical ER in vivo. A failure to transport cholesterol to the ER would render the cells dependent on endogenous cholesterol synthesis for production of cortisol. We analyzed expression of SREBP-2 target genes, whose expression is tightly linked to ER cholesterol content (Brown and Goldstein, 1997) . Adrenal SREBP-2 target gene expression was far higher in Aster-B-deficient mice than in WT mice ( Figure 7E ), indicating that the ER is starved for cholesterol in the absence of Aster-B. In addition, nuclear fractions from Aster-B-deficient adrenal glands showed dramatically increased levels of mature SREBP-2, despite comparable levels of the membrane-bound precursor, indicating that Aster-B deficiency promotes SREBP-2 processing ( Figure 7F ). Levels of SR-BI were normal in Aster-B-deficient mice, indicating that the phenotype was not a consequence of SR-BI deficiency ( Figure 7F ).
Cholesterol esters are utilized, particularly during times of stress, for generating corticosteroids. Although serum cholesterol levels did not differ significantly between WT and Aster-B knockout mice ( Figure 7G ), basal serum corticosterone levels were lower in Aster-B-deficient mice than in controls ( Figure 7H ). The induction of stress through an overnight fast exacerbated this deficiency (Hoekstra et al., 2008) . By contrast, levels of epinephrine and dopamine (nonsteroid mediators made by the adrenal medulla) were not different between groups ( Figure S6F ).
Collectively, our data demonstrate that Aster-B moves cholesterol from the PM to the ER downstream of the HDL receptor SR-BI ( Figure S7 ). To our knowledge, Aster-B is the only putative mammalian PM-ER cholesterol transporter to show a loss-offunction phenotype in vivo and to be implicated in the transport of HDL-derived cholesterol.
DISCUSSION
How cholesterol moves between the PM and the ER in mammalian cells has been a long-standing conundrum. Recent studies have emphasized the ability of the ER to sense fluctuations in the ''accessible'' pool of PM cholesterol and to link these with regulation of the sterol-sensing SREBP-2 pathway (Das et al., 2014; Infante and Radhakrishnan, 2017) . Our work reveals that the equilibrium between ''accessible'' PM cholesterol and the ER pool is maintained, at least in part, through a cholesteroldependent switch involving the Aster family of ER-anchored transporters. When levels of cholesterol in the PM rise above homeostatic levels, Asters form bridges from the PM to the ER, and the sterol-binding ASTER domain extracts cholesterol from the PM and moves it down the concentration gradient to the ER. One member of this family, Aster-B, is highly expressed in steroidogenic tissues and is required for the ability of HDL cholesterol to move to the ER in adrenocortical cells. These studies outline a critical function for Aster-B in the nonvesicular transport of cholesterol in vivo and suggest that members of the Aster family could play important roles in facilitating ER-PM cholesterol movement in other cell types. Many putative sterol-trafficking proteins have been identified by in vitro experiments. However, defining their physiologic roles has been challenging because of the absence of clear loss-offunction phenotypes. It has been suggested that assigning functions to these proteins may be complicated by redundancy, but an alternative possibility is that the various lipid-binding proteins have not yet been associated with the correct biological function. Defining the physiologic roles of mammalian START proteins has proven particularly difficult. StARD1 is the only family member that has been shown to mediate cholesterol trafficking in vivo in both mice and humans (Caron et al., 1997; Lin et al., 1995) . StARD1 mutations inhibit cholesterol trafficking to the inner mitochondrial membrane and cause a massive accumulation of cholesterol esters in the adrenal-a phenotype opposite that elicited by Aster-B deficiency.
START-like domains with homology to the ASTER domain have been identified through bioinformatics approaches in plants and other lower organisms (Elbaz-Alon et al., Gatta et al., 2015; Khafif et al., 2014; Murley et al., 2015) . In yeast, a family of six Ltc proteins contain combinations of one or more GRAM domains, START-like domains, and transmembrane segments (Elbaz-Alon et al., 2015; Gatta et al., 2015; Horenkamp et al., 2018; Murley et al., 2015; Tong et al., 2018; Wong and Levine, 2016) . Although they share some structural features with yeast START-like domain proteins, one-to-one orthologs for the Asters are restricted to vertebrates, where they appear to have evolved alongside SR-BI and other proteins involved in lipoprotein metabolism. Higher organisms must move lipids between tissues to maintain systemic homeostasis. It is therefore logical that mammals would have evolved specific transporters to facilitate the movement of lipoprotein-derived cholesterol into cells. Indeed, key residues lining the ASTER domain sterol-binding pocket are not conserved in yeast START-like domain proteins, resulting in a distinct mode of ligand binding.
One of the most remarkable features of the Aster proteins is their ability to localize to the PM based on the level of membrane cholesterol. Interestingly, NPC1L1, which facilitates intestinal cholesterol absorption, also relies on a cholesterol-mediated switch (Ge et al., 2008) . NPC1L1 is internalized with cholesterol at the PM and then traffics to endosomes, an effect dependent on a sterol-sensing domain in NPC1L1. The mechanism of Aster recruitment by cholesterol is distinct. The Aster GRAM domain, which binds phosphatidylserine, is necessary and sufficient for PM localization in response to cholesterol loading. Phosphatidyl-serine is enriched on the inner leaflet of PM; hence, phosphatidylserine binding by the GRAM domain could mediate PM localization of Asters. An open question is why the Aster GRAM domain is able to recognize phosphatidylserine only in the presence of excess membrane cholesterol. Additional studies will be needed to test whether cholesterol loading changes the biophysical presentation of phosphatidylserine, stimulates the generation of other lipids, or triggers the production of secondary messengers.
While ER-PM contacts are stable and prominent in yeast, they appear to have more dynamic and tissue-adapted roles in mammalian systems (e.g., STIM1, E-Syts) (Zhang et al., 2005) . While this paper was under review, it was reported that Gramd2 and Gramd1a (Aster-A) are localized in ER-PM contact sites (Besprozvannaya et al., 2018). Gramd2 has an N-terminal GRAM domain and is anchored in the ER like the Aster proteins, but lacks the central sterol-binding fold. Asters are unique among known ER-PM contact proteins in their ability to form membrane bridges in a cholesterol-dependent manner. Interestingly, we observed that ER-PM contacts containing Aster-B were frequently located in the same ER tubules in which ORP5, E-Syt2, or E-Syt3 were found, but some contacts appeared to contain only Aster-B, consistent with the idea that they are functionally distinct. The questions of whether other proteins such as E-Syts help to stabilize Aster-dependent contacts and whether lipid transport by ORP5 and Asters is coordinated remain to be addressed.
The phenotype of Aster-B-deficient mice suggests principles that are likely to be relevant to understanding the functions of other Aster family members in other contexts. We expect that trafficking of cholesterol from the PM to the ER and vice versa may be critical for lipid homeostasis in many, if not all, mammalian cell types. Furthermore, the cell type-selective expression of Aster proteins in tissues with active lipid metabolic programs suggests that Asters are likely to play important roles in sterol transport in other tissues. For example, while Aster-B is expressed at low levels in the liver, other Asters are abundant. Given that the liver is an important destination for HDL cholesterol, it will be of interest to determine whether Aster proteins function downstream of SR-BI in that tissue. The high level of Aster-A expression in the brain suggests that this family member could be particularly important for sterol trafficking in neurons, about which very little is known. Finally, the numerous links between defective cholesterol metabolism and human pathologies underscore the importance of understanding the mechanisms of cellular sterol transport. Uniting the function of individual cholesterol trafficking proteins with their physiologic roles will advance our understanding of physiology and may highlight opportunities to target lipid metabolism in the treatment and diagnosis of human disease. (E) Representative electron micrographs of adrenal fasciculata cells. Samples were fixed and processed as described in the STAR Methods. Lipid droplets, nuclei, and mitochondria are indicated (LD, N, MT; n = 2 mice, 35-52 sections each). 
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All mice were housed in a temperature-controlled room under a 12 hr light-dark cycle and under pathogen-free conditions. Mice were placed on a chow diet. Experiments were performed in male and female mice. Investigators were blinded to group allocation for some but not all studies. Aster-B global knockout mice were generated at Mouse Biology Program facility on a C57BL/6N background using the CRISPR/Cas9 strategy outlined in Figure S5B . All animal experiments were approved by the UCLA Institutional Animal Care and Research Advisory Committee. Experimental mice were sacrificed at ages 6-12 weeks unless otherwise specified for histological, serum, lipid, and gene expression analyses.
Cell Culture A431, CHO-K1, 3t3-L1 and HeLa cells were obtained from the American Type Culture Collection. They have been previously verified by STR testing and were confirmed to be mycoplasma-free by regular testing. CHO-K1 and HeLa cells were transfected with Fugene 6 (Promega) following manufacturer's protocol. X-tremeGENE HP DNA or Genecellin transfection reagents were used for transfecting A431 cells. A431, 3T3-L1 and HeLa stable cells were grown in monolayer at 37 C in 5% CO2. The cells were maintained in medium A (DMEM containing 100 units/ml penicillin and 100 mg/ml streptomycin sulfate) supplemented with 10% FBS. CHO-K1 cells were grown in medium B (a 1:1 mixture of F-12K medium and Dulbecco's MEM containing 100 units/ml penicillin and 100 mg/ml streptomycin sulfate) supplemented with 10% FBS. Cholesterol-depleting medium was medium A supplemented with 1%-5% lipoprotein-deficient serum (LPDS). Unless otherwise specified, cells were cholesterol loaded using 200 mM cholesterol: methyl-b-cyclodextrin (randomly methylated, Sigma C4555) complexes.
METHOD DETAILS
Construction of Plasmids and Stable Cell Lines
Mouse Aster-A, -B, and -C and truncations were PCR amplified from Mus musculus C57BL/6J cDNA and cloned into pDonr221 by Gateway cloning (BP reaction, ThermoFisher), pEntr4-GFP-C1 or pEntr4-GFP-N2 by Gibson assembly (NEB Gibson Assembly kit) (Gibson et al., 2009) . For some studies, human Aster-B (1-738) was used as indicated. For use in transient transfections of GFPtagged Aster proteins in CHO-K1 cells, pDonr221 plasmids were LR recombined into a pDest53 destination vector containing a CMV promoter and an N-terminal eGFP. For generation of stable C-terminal GFP-tagged Aster protein A431 cells, pEntr-GFP-N2 constructs were LR recombined into a retroviral pBabe DEST vector containing an SV40 promoter. For generation of stable N-terminal GFP-tagged Aster protein A431 cells, pEntr-GFP-C1 constructs were LR recombined into a pLenti Destination vector containing a CMV promoter. After infection, GFP positive cells were selected by flow cytometry based on expression level. PM-mCherry was generated by fusing a plasma membrane targeting sequence of GAP-43 (MLCCMRRTKQVEKNDEDQKI) synthesized as DNA oligo (Biomers, Germany) and inserting into the N terminus of mCherry ( Figure 5D ; Video S1). SR-BI cDNA (transcript variant 2, NM_001082959.1) was amplified from A431 cDNA with primers SR-BI sense-BglII (atctAGATCTaccATGGGCTGCTCCGC CAAAG) and SR-BI anti-NotI(atttgcggccgcgtgtgtgcaggtgtgcaa), inserted into mammalian expression vector with a EF1a promoter and puromycin selection marker ( Figures 7A-7C and Figure S6B ). First A431 cells with a stable expression for SR-BI were selected using 1 mg /ml puromycin. These cells were then transfected with GFP-Aster-B (human) and single cell clones with stable expression of SR-BI and GFP-Aster-B were selected with 500 mg / ml G418. Aster-B PH domain-GFP and control GFP constructs were packed into retrovirus to infect A431 cells in the presence of 6 mg/ml polybrene (Millipore). Cells were selected with 1 mg/ml puromycin for 1 week before using in experiment and used as a pool without further subcloning ( Figure 5D , E; Videos S2, S3, and S4). BFP-KDEL (Friedman et al., 2011) was amplified by PCR, inserted into an AAVS1 safe harbor integration vector (Lombardo et al., 2011) with puromycin selection marker. E-syt2 and E-syt3 (Giordano et al., 2013) , and OSBPL5 cDNA (from HeLa cDNA, NM_ 020896.3) amplified by PCR, and the CAAX box (KLNPPDESGPGCMSCKCVLS) synthesized as DNA oligos (Biomers, Germany), were fused to the C terminus of mCherry, and inserted into the safe harbor vector with blasticidin selection marker.
A431 cell lines double expressing BFP-KDEL plus the mCherry fusion proteins of interest were generated through CRISPR/Cas9 mediated AAVS1 safe harbor co-integration. Briefly, cells were co-transfected with two constructs (BFP-KDEL with puromycin selection and mCherry fusion protein with blasticidin selection) plus a third Cas9/sgRNA construct (backbones kind gifts from Feng Zhang) (Ran et al., 2013) targeting the AAVS1 locus. Transfected cells were selected with 1 mg/ml puromycin and 5 mg/ml blasticidin for 7 days and used as pools for the experiments. Plasmids and plasmid sequences are available upon request.
Protein Expression and Purification
For crystallization studies, the mouse Aster-A protein (334-562) was cloned into pGEX2T (GE Healthcare) with a TEV protease site. Aster-A was expressed in E. Coli Rosetta (DE3) (Novagen) by growing the transformed Rosetta (DE3) at 37• C in 2xTY until A600nm = 0.1, then inducing with 40 mM Isopropyl-D-1-thiogalactopyranoside (IPTG) and growth overnight at 20•C. The bacterial cells were lysed by sonication in a buffer containing 1x PBS, 1 mM Dithiothreitol (DTT) and Complete EDTA-free protease inhibitor (Roche). The soluble protein was bound to glutathione Sepharose (GE healthcare), and washed with a buffer containing 1x PBS, 0.5% Triton X-100, 0.5mM TCEP. Then the bound protein was washed with TEV cleavage buffer containing 50 mM Tris/Cl pH 7.5, 100 mM NaCl, 5% glycerol and 0.5mM TCEP. The protein was eluted from the resin using TEV protease. After the GST purification excess 25-hydroxy cholesterol was added from a 10 mM stock solution dissolved in ethanol and the complex purified on a Superdex S-200 column in 50 mM Tris/Cl pH 7.5, 100 mM NaCl and 0.5mM TCEP. The peak fractions were concentrated to 11.1 mg/ml and used for the crystallization experiments.
For binding and transfer studies Aster domains (Aster-A 261-576 , , ) were expressed by baculovirus in Sf-9 insect cells with an N-terminal FLAG tag and a C-terminal 6x His Tag. Proteins were expressed with P3 baculovirus for 48 hours at 27 C. Cells were recovered by centrifugation, lysed by sonication. Insoluble material was pelleted at 16,000xg for 40 minutes. Soluble protein was first purified using a Ni-NTA column (QIAGEN, 30210) and eluted with 250mM imidazole PBS buffer after extensive washing. Following dialysis proteins were purified using FLAG M2 affinity gel (Sigma A2220) columns and eluted with 100 mg/mL 1x FLAG peptide after washing for ten column volumes. Proteins were then either dialyzed to remove the FLAG peptide or purified further by size exclusion chromatography. The B Gram domain was expressed in Sf9 cells with a 6xHis tag ) and purified as described above. N-terminal expression constructs were transformed in Rosetta 2 (DE3) cells (Novagen). LB precultures were diluted into large-scale expression cultures and grown at 37 C to an A 600 of 0.6-0.8, then induced with 0.5 mM IPTG at 18 C for 16 hours with shaking. Protein was then purified in PBS + 0.5mM DTT using glutathione agarose resin (Pierce PI16100) and eluted with 10mM GSH peptide in 50mM Tris, 150mM NaCl, pH 8.0. Protein was then dialyzed to remove GSH peptide. HMBP-3C-STAR.66-285 (StAR) was a gift from Nikolai Sluchanko (Addgene plasmid # 100094). Soluble StAR was first purified using a Ni-NTA column (as above) and subsequently purified using amylose resin (NEB E8021S) and eluted with 10 mM maltose in 50mM Tris, 150mM NaCl, pH 8.0. Protein was then dialyzed to remove maltose.
NBD-Cholesterol Binding Experiments
Fluorescent sterol binding assays were carried out as previously described (Petrescu et al., 2001; Wei et al., 2016) in 384-well black flat-bottom plates and equilibrated at room temperature for 1 hour. Measurements were made using a CLARIOstar (BMG LABTECH) microplate reader. The NBD fluorophore was excited with l(ex) = 470 nm and l(em) = 525 and plotted using Prism software. Dissociation constants (K D ) were determined by nonlinear regression analysis of dose-response curves.
GST Agarose Assay for [ 3 H]Cholesterol Binding
Reactions were carried out in binding buffer (0.003% Triton X-100 in 1 x PBS) containing 150 nM of Aster-B ASTER protein and [ 3 H]cholesterol. After incubation for 30 min at room temperature, the mixture was incubated with pre-equilibrated of glutathione agarose resin (Pierce PI16100) at 4 C for 2 h, then loaded onto a column and washed. The protein-bound [ 3 H]cholesterol was eluted with 10 mM GSH peptide and quantified by scintillation counting. For competition experiments with unlabeled sterols, the assays were carried out in the presence of ethanol containing the indicated unlabeled sterol (0 -10 mM).
Liposome Preparation
Liposomes were generated by drying lipids in glass tube under liquid nitrogen. Lipid films were then resuspended in 50 mM HEPES, 120 mM potassium acetate buffer ± 0.75M sucrose where indicated. Lipid suspensions were then vortexed and incubated for 30 minutes at 37 C (2mM total lipid concentration). Suspensions were then snap frozen in liquid nitrogen and thawed rapidly at 37 C five times. Light liposomes were prepared by extruding through 100 nm polycarbonate filters. Heavy liposomes containing sucrose were prepared by extruding through a 400 nm polycarbonate filter, then washing several times in 50 mM HEPES, 120 mM potassium acetate buffer with no sucrose. Liposome sizes were confirmed using an N4 Dynamic Light Scattering instrument.
Crystallization and X-ray Structure Determination Crystals of the Aster-A (334-562):25-hydroxycholesterol complex were obtained using sitting drop vapor diffusion at room temperature. Crystals were grown using 0.2 M NaCl, 0.1 M sodium cacodylate pH 6.0 and 8% PEG 8000 (condition E3 Proplex, Molecular Dimensions). Data were collected to 2.9 Å on the I03 beamline at Diamond Light Source, UK. Data were processed using XDS (within Xia2) and Pointless/Aimless (within CCP4). The structure was solved using molecular replacement using Phaser (within CCP4) and the first StARkin domain of S. cerevisiae Lam4 (pdb code 5YQJ, (Tong et al., 2018) as a model. Model fitting and refinement were performed using Coot, Refmac (within CCP4), PDB-REDO and Phenix.
Live Cell Imaging
For time-lapse fluorescence imaging, cells were plated in poly-d-lysine coated 35 mm glass bottom dishes (Mat-tek) and, when indicated, transfected 48hr prior to imaging. Images were acquired using an Inverted Leica TCS-SP8-SMD Confocal Microscope, equipped with CO 2 /temperature controlled Tokai Hit system for imaging of live cells at 37 C with 5% CO 2 . Images were deconvolved using Huygens Professional software. Brightness and contrast were adjusted with ImageJ software. For some experiments cells were sorted for expression of GFP. TIRF imaging was performed in glass bottom m-slide 4 well plates (Ibidi) with a Nikon Eclipse Ti-E N-STORM microscope, equipped with Andor iXon+ 897 back-illuminated EMCCD camera and 3 100 Apo TIRF oil objective NA 1.49, a 65 mW Argon line combined with Quad filter was used for visualization of TIRF and epifluorescence ( Figure 3E ). Live cell TIRF imaging was performed similarly at 37 C, 5% CO 2 with EMBL GP168 incubator controller ( Figure 5E ; Videos S3 and S4).
For automated quantification of TIRF images, cells were fixed with 4% PFA for 15 min, permeabilized with PBS/0.1% Triton for 5 min and stained with DAPI 5 mg/ml and 0.2 mg/ml CellMask Deep Red (Life Technologies) in PBS for 15 min. TIRF images were acquired for GFP-AsterB together with epifluorescent images for DAPI and CellMask Deep Red. These images were automatically quantified using CellProfiler (Carpenter et al., 2006) and the resulting data analyzed with Python/Pandas. For Airyscan superresolution microscopy, cells in 8 well Lab-Tek II Chambered coverglass (Thermofisher) were imaged with a Zeiss LSM 880 confocal microscope equipped with an Airyscan detector using a 63 3 Plan-apochromat oil objective, NA 1.4. Live cell imaging was performed at 37 C, 5% CO 2 with incubator insert PM S1 and definite focus hardware autofocus system. Images were Airyscan processed automatically using the Zeiss Zen2 software package ( Figure 3D ; Video S1).
For dual color live cell TIRF imaging, A431 cells stably expressing GFP-Aster-B and Cherry-ORP5 were seeded in 4-well LabTek II live cell chamber slides. After two days cells were incubated with DMEM containing 5% LPDS for 8 h. Live cell TIRF imaging was performed in FluoroBrite DMEM containing 5% LPDS: TIRF video microscopy with a frame rate of one image per minute was initiated 50 s after addition of 1 mM cholesterol/cyclodextrin. Images were acquired with a GE Deltavision OMX SR instrument equipped with a 60x Apo-N oil immersion objective. Images were deconvolved using the softWoRx 7.00 software (GE Healthcare).
For imaging Aster-B with PM and other contact site marker proteins, A431 cells stably expressing BFP-KDEL and mCherry fusion proteins of ER/PM contact site markers were seeded in 8-well LabTeK II live cell chamber slides. After 24 h cells were washed with PBS and transiently transfected with GFP-Aster-B expression constructs using X-tremeGENE HP DNA or Genecellin transfection reagents in DMEM containing 5% lipoprotein deficient serum (LPDS). After 24 h cells were switched to FluoroBrite DMEM containing 5% LPDS, with or without 100 -200 mM cholesterol/cyclodextrin. Cells were imaged 15 to 65 min after cholesterol administration using a Zeiss LSM 880 Airyscan microscope equipped with a 63x Plan-Apochromat oil immersion objective. Images were Airyscan processed and brightness and contrast adjusted with ImageJ. Images from the bottom section of a cell were used for the quantification of the overlap of GFP-Aster-B with contact-site marker proteins. The images were thresholded to select GFP-Aster-B and contact site marker structures and the pixel overlap of the segmented structures was calculated with the JaCOP plugin for ImageJ. For each condition, 9-13 cells from 2 independent experiments were quantified.
Phospholipid Binding Assays
Lipid binding analysis of 6xHis-tagged B GRAM (Aster-B 1-337 ) was conducted using PIP Strips (Echelon Biosciences), with each spot containing 100 pmol of active lipids. Membranes were blocked with PBS Tween (PBST) solution (supplemented with 3% fatty acid free BSA) for 1 hr at room temperature, and incubated with B GRAM fusion protein in blocking buffer for 1 hr. After three washes, the membranes were blotted with anti-His antibody (Biorad, MCA1396GA). The strip contained 15 different types of lipids. LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; PI, phosphatidylinositol; PI(3)P, phosphatidylinositol 3-phosphate; PI(4)P, phosphatidylinositol 4-phosphate; PI(5)P, phosphatidylinositol 5-phosphate; PE, phosphatidylethanolamine; PC, phosphatidylcholine; S1P, sphingosine-1-phosphate; PI(3,4)P2, phosphatidylinositol 3,4 -phosphate; PI(3,5)P2, phosphatidylinositol 3,5-phosphate; PI(4,5)P2, phosphatidylinositol 4,5-phosphate; PI(3,4,5)P3, phosphatidylinositol 3,4,5-phosphate; PA, phosphatidic acid; PS, phosphatidylserine. Results were confirmed with a FLAG tagged B GRAM Fusion construct.
Gene Expression Analysis
Total RNA was isolated using TRIzol reagent (Invitrogen) and reverse transcribed with the iScript cDNA synthesis kit (Biorad). cDNA was quantified by real-time PCR using SYBR Green Master Mix (Diagenode) on an ABI 7900 instrument. Gene expression levels were determined by using a standard curve. Each gene was normalized to the housekeeping gene 36B4 and was analyzed in duplicate. Primers used for real-time PCR are available upon request.
QUANTIFICATION AND STATISTICAL ANALYSIS
Experimental Replicates and Quantification
Replicates are described in the figure legends. For cellular assays, n corresponds to the number of experimental replicates. For animal experiment, n corresponds to the number of mice used per genotype or condition. Each experiment was repeated using at least two cohorts of mice. All data were represented as mean SEM (standard error) as described in the figure legends.
Statistical Analysis
All data are presented as mean ± SEM and analyzed using Microsoft Excel and Prism (Graphpad). Student's t test was used for single variable comparison between two groups. Two-way ANOVA followed by Bonferroni posttests was used to examine interactions between multiple variables. Data are presented as ± SEM p < 0.05 was considered to be statistically significant and is presented as * p < 0.05, ** p < 0.01, *** p < 0.001, or **** p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
The PDB Code for the crystallography data is PDB: 6GQF. (legend continued on next page)
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